im injection sites for b12 Reel by @edupointmed (@edupointmed) · July 21, 2026 What is the optimal site

It is worth noting that lipotropic injections should not be considered a weight loss treatment they are rather a supplement to an existing diet and exercise regimen

Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs

Common injection sites include the abdomen (2 inches from navel), upper thighs, or upper arms

The rationale was that direct delivery to the joint would maximize local efficacy while minimizing systemic exposure

5-Amino-1MQ + GLP-1 research A commercially promoted pairing with GLP-1 agonists based on theoretical complementary mechanisms no human study of this combination has been published